Status:
UNKNOWN
Effectiveness for Interventions to Minimize Surgical Site Infections
Lead Sponsor:
Dallas VA Medical Center
Conditions:
Infections
Eligibility:
All Genders
18-95 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate two different simple and inexpensive extra treatments during colorectal surgeries to see if this will reduce the rate of post operative infections
Detailed Description
The population for inclusion for this study will be drawn from the patients undergoing elective transabdominal colorectal surgery. This population was chosen due to its inherently high rate of superfi...
Eligibility Criteria
Inclusion
- VA patients getting transabdominal,elective colorectal procedures
- willing and capable of giving self informed consent
Exclusion
- patients unable to give informed consent
- emergency colorectal procedures
- transanal procedures
- patients who have contaminated or dirty wounds that would preclude attempts at skin closure at the conclusion of the procedure
- patients undergoing appendectomy
- patients undergoing intraabdominal procedures not including surgical resection of the colon or rectum (ie.procedures involving small bowel , stomach)
- patients with pre/op creatinine clearance less than 20ml/min
- patients with known allergy or hypersensitivity to gentamicin
- patients that have received gentamicin within 2 weeks of potential study date
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2012
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01153191
Start Date
August 1 2010
End Date
December 1 2012
Last Update
November 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VANTXHCS
Dallas, Texas, United States, 75216